1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Hires the Washington Research Group

Our Firm

November 18, 2011

Guggenheim Securities Hires the Washington Research Group

WRG’s Public Policy Insights Will Be Combined with Guggenheim’s Existing Analyst Team to Create a Differentiated and Impactful Research Offering

Guggenheim Partners, LLC, a diversified financial services firm, announced today that the team of analysts at the Washington Research Group (WRG) is joining Guggenheim Securities. Formerly of MF Global, WRG is a Washington, D.C.-based, policy-focused investment research team that provides leading institutional equity investors with insights and analysis on the impact of government policy on investment opportunities.

“This is a transformative event for the equities business of Guggenheim Securities as we build out our research capabilities,” said Alan Schwartz, Executive Chairman of Guggenheim Partners. “The addition of WRG is illustrative of Guggenheim’s dedication to bring insights to our clients, as well as our commitment to grow our business in the face of difficult market conditions. The combination of our existing research capabilities with WRG’s deep insights on public policy developments enhances our ability to provide thoughtful insights to our clients. Furthermore, the compatibility of our two corporate cultures and commitment to excellence bodes well for success.”

WRG’s 14 policy strategists will join with Guggenheim’s securities analysts to produce integrated products of high quality public policy commentary and fundamental analysis. The first combined commentary is expected to reach clients in the near future.

“The addition of the high caliber WRG analyst team and their focus on public policy investment themes will help us further deliver attractive and actionable ideas to our clients,” said Lance Klima, Senior Managing Director of the equities division at Guggenheim Securities. “We warmly welcome the entire team to Guggenheim and look forward to working with them.”

“We are delighted to be joining such a dynamic and forward-thinking firm,” said Ed Garlich, WRG Group head and founder. “We feel that WRG’s policy analysts will bring unique new perspectives to the Guggenheim research offering and we look forward to continuing to serve institutional investors in the U.S. and around the world.”

About Washington Research Group

Washington Research Group, founded more than 35 years ago, is a 17-member policy analyst team providing institutional investors with insights about the impact of Washington policy on their investment decisions. The team aims to be the professional investor’s “one stop shop” for all things Washington, and its clients include some of the largest mutual funds and hedge funds in the country. The team covers a broad range of sectors, including health care, financial services, defense, national security, international trade, media/telecommunications, agribusiness, biofuels, tobacco, and corporate tax. The team has consistently ranked in the top three groups for Macro/Washington research in Institutional Investor magazine’s All-American Research Team poll.

About Guggenheim Partners

Guggenheim Partners, LLC is a privately held global financial services firm with more than $125 billion in assets under management. The firm provides asset management, investment banking and capital markets services, insurance, institutional finance and investment advisory solutions to institutions, governments and agencies, corporations, investment advisors, family offices and individuals. Guggenheim Partners is headquartered in New York and Chicago and serves clients from more than 25 offices in 10 countries.

March 23, 2018

Seamus Fernandez to Join Guggenheim Securities as Pharmaceuticals Analyst

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Seamus Fernandez will join the firm in June as a Senior Analyst and Senior Managing Director in a planned expansion of the firm’s Healthcare Research team. He will focus on companies in the pharmaceuticals industry globally and coordinate the firm’s research coverage of therapeutics.

Read More

March 19, 2018

Michael Schmidt to Join Guggenheim Securities as Biotech Analyst

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Michael Schmidt, Ph.D. will join the firm in June as a Senior Analyst and Senior Managing Director in a planned expansion of the firm’s Healthcare Research team. Dr. Schmidt will focus on the coverage of Biotech companies, working closely with our growing therapeutics team.

Read More

February 21, 2018

Guggenheim 1Q Fixed-Income Outlook: Upgrading Quality and Shortening Duration Amid Late-Cycle Behavior in Bond Markets

NEW YORK, NY – Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, today provided its First Quarter 2018 Fixed-Income Outlook, “Walking the Risk Tightrope.”

Read More

© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.